SciBase Initiates Collaboration With Inderes for Commissioned Research
SciBase Initiates Collaboration With Inderes for Commissioned Research
STOCKHOLM, Jan. 30, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a pioneer in early detection and prevention in dermatology initiates cooperation with Inderes () for ongoing services related to commissioned research. This collaboration aims at providing high-quality equity research on SciBase Holding AB stock.
斯德哥爾摩，2024 年 1 月 30 日 /PRNewswire/-- 皮膚病學早期發現和預防領域的先驅SciBase Holding AB（“SciBase”）（STO：SCIB）開始與Inderes（）合作，提供與委託研究相關的持續服務。此次合作旨在爲SciBase Holding AB股票提供高質量的股票研究。
The research reports, analyst comments and interview videos will be published and made available on inderes.se, inderes.dk and inderes.fi with over 70,000 active members, as well as through Inderes' channels on social media and other investor platforms. The first analysis is planned to be carried out in the first quarter of 2024. Inderes welcomes all investors to discuss and ask questions from the analyst on forum.inderes.se once the research is published.
研究報告、分析師評論和訪談視頻將在擁有70,000多名活躍成員的inderes.se、inderes.dk和inderes.fi上發佈和公佈，也將通過Inderes的社交媒體和其他投資者平台上的渠道發佈。第一次分析計劃在2024年第一季度進行。研究報告發表後，Inderes歡迎所有投資者在forum.inderes.se上討論並向分析師提問。
The main purpose of the collaboration is to:
合作的主要目的是：
- Increase investor awareness of SciBase
- Help investors better understand SciBase
- Create a communication channel between the investors and SciBase
- Improve the price formation and liquidity of SciBase's stock
- 提高投資者對 SciBase 的認識
- 幫助投資者更好地了解 SciBase
- 在投資者和 SciBase 之間創建溝通渠道
- 改善 SciBase 股票的價格形成和流動性
For additional information, please contact:
欲了解更多信息，請聯繫：
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]
Michael Colerus, CFO, tel. +46703413472, e-mail: [email protected]
Pia Renaudin，VD，電話 +46732069802，電子郵件：[email protected]
邁克爾·科勒魯斯，首席財務官，電話：+46703413472，電子郵件：[email protected]
Certified Advisor (CA):
認證顧問 (CA)：
Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]
Vator 證券
電話：+46 8 580 065 99
電子郵件：[電子郵件保護]
About SciBase
關於 SciBase
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
SciBase 是一家全球醫療技術公司，專門從事皮膚病學的早期發現和預防。SciBase 開發並商業化了 Nevisense，這是一個獨特的即時護理平台，它結合了人工智能（人工智能）和先進的 EIS 技術，可提高診斷準確性，確保積極的皮膚健康管理。
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
我們的承諾是最大限度地減少患者的痛苦，使臨床醫生能夠通過及時的檢測和干預來改善和挽救生命，並降低醫療成本。
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
SciBase建立在瑞典斯德哥爾摩卡羅林斯卡研究所20多年的研究基礎上，是皮膚病學進步領域的領導者。
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press-releases and financial reports can be found here :
該公司自2015年6月2日起在納斯達克第一北方成長市場交易所上市。要了解更多，請訪問 。 所有新聞稿和財務報告都可以在這裏找到：
About Inderes
關於 Inderes
Inderes connects investors and listed companies, with the aim of democratizing information in the financial markets. Inderes helps over 400 Nordic listed companies to better serve their shareholders. Inderes' Nordic community consists of over 70,000 active investors.
Inderes將投資者和上市公司聯繫起來，旨在實現金融市場信息的民主化。Inderes幫助400多家北歐上市公司更好地爲股東服務。Inderes的北歐社區由超過70,000名活躍的投資者組成。
The following files are available for download:
以下文件可供下載：
|
Inderes PR |
|
Inderes PR |
譯文內容由第三人軟體翻譯。